Insider Transactions in Q1 2022 at Castle Biosciences Inc (CSTL)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.76%
|
$398,340
$45.19 P/Share
|
|
Mar 29
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.29%
|
$398,340
$45.41 P/Share
|
|
Mar 15
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.68%
|
$318,672
$36.76 P/Share
|
|
Mar 14
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.64%
|
$336,376
$38.37 P/Share
|
|
Feb 23
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.14%
|
$345,228
$39.28 P/Share
|
|
Feb 22
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.1%
|
$345,228
$39.08 P/Share
|
|
Feb 10
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-1.54%
|
$398,340
$45.49 P/Share
|
|
Feb 09
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
8,852
-2.01%
|
$407,192
$46.56 P/Share
|
|
Jan 24
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
14,631
-3.17%
|
$512,085
$35.44 P/Share
|
|
Jan 20
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
15,604
-3.27%
|
$546,140
$35.3 P/Share
|
|
Jan 18
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
2,470
-0.51%
|
$86,450
$35.25 P/Share
|
|
Jan 10
2022
|
Derek J Maetzold Pres. & Chief Exec. Officer |
SELL
Bona fide gift
|
Indirect |
122,181
-100.0%
|
-
|
|
Jan 05
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
16,353
-1.99%
|
$686,826
$42.08 P/Share
|
|
Jan 04
2022
|
Daniel Bradbury Director |
SELL
Open market or private sale
|
Indirect |
16,353
-2.43%
|
$703,179
$43.88 P/Share
|